65-year-old man initially experienced difficulty forming his tie and felt unsteady while driving. Days later, these symptoms were followed by periods of dizziness and vague episodes of confusion that he felt were "out of character." The patient was extremely concerned, especially given a strong family history of strokes. With an unremarkable physical examination, laboratory tests, and brain imaging, the patient's symptoms were attributed to his inadvertent ingestion of codeine-containing medication and to multiple increasing life stressors, including recent prostatectomy for prostate cancer.
DIAGNOSIS: Sporadic Creutzfeldt-Jakob disease (sCJD). Genetic sequencing of the proteinase-resistant protein (PrP) ruled out the presence of a pathologic genetic mutation in the coding region of the PrP gene. Therefore, the prion disease in this case was not familial.
DISCUSSION
Creutzfeldt-Jakob disease (CJD) is a rare but invariably fatal neurodegenerative illness caused by accumulation of an abnormal form of a PrP, or prion, in the brain parenchyma. Detection of the pathologic prion (PrP Sc ) in brain tissue that also demonstrates neuropathologic changes of spongiform degeneration, neuronal death, and astrocytic gliosis allows for the definitive diagnosis of CJD (1-3) (Figure 2 ). Multiple forms of CJD have been described, with sporadic being the most commonly documented form (85% of cases). Although routes or sources of infection are not known, six molecularly distinct phenotypes of sCJD have been defined (2) . Each subtype differs with regard to various clinicopathologic features (including age of onset, disease duration, EEG and 14-3-3 findings) and pattern of histopathologic changes (2, 4, 5) .
Other forms of CJD are variant, familial, and iatrogenic CJD. Variant CJD has been reported mainly in Europe, where ingestion of products from cattle infected with bovine spongiform encephalopathy is the suspected route of transmission and has received much worldwide press coverage in recent years. Familial CJD is exceedingly rare and is inherited as a germline mutation in the human prion protein gene (PRNP) (6) . Iatrogenic causes include ingestion of contaminated human hormone supplements, corneal transplantation, and transplantation of cadaveric dura mater, which was previously common in Japan before becoming the focus of heavy public scrutiny (7) (8) (9) (10) .
CJD, especially in its early stages, is an extremely challenging disease to diagnose. The clinical symptoms are relatively nonspecific and overlap with other dementia disorders. The characteristic EEG findings are seen in only 66% of patients and have a reported specificity of 74% (11, 12) . Detection of 14-3-3 protein in cerebrospinal fluid can support the diagnosis and is positive in over 90% of patients with CJD. The presence of this protein should not be considered pathognomonic, however, as it can also be detected in the setting of encephalitis, stroke, hypoxic brain injury, intracranial bleed, and Alzheimer's disease (13, 14) . Computed tomography scans of the brain may show either nonspecific atrophy or no abnormality at all. Brain biopsy can be conclusive, but the elevated risk of disease transmission makes this a rarely plausible option. Given this diagnostic dilemma, MRI of the brain is an increasingly useful tool in the evaluation of patients with suspected CJD. Most importantly, MRI is helpful in excluding other possibly treatable causes of encephalopathy.
Clinical presentations of CJD are variable, depending on the stage of disease. A majority of patients demonstrate rapidly progressing mental decline, with onset of dementia, ataxia, and sometimes visual disturbances within a few weeks to several months. Development of myoclonus often occurs with disease progression, coinciding with periodic sharp wave complexes that are detectable on EEG (7, 15) . The late phase begins after several months and is dominated by akinetic mutism, with death typically occurring within a year.
Early in the disease course, brain MRI may be without abnormality. In fact, absence of significant findings on all MRI sequences throughout the course of sporadic CJD has been reported in some cases (16, 17) . However, the large majority of patients with CJD demonstrate the characteristic imaging features of the disease, specifically when fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging (DWI) sequences are employed as part of the imaging protocol. It has been repeatedly shown that DWI is more sensitive in the detection of parenchymal abnormalities than FLAIR (18) (19) (20) . Another benefit of DWI, especially in patients with myoclonus, is the short acquisition time (approximately 30-45 seconds). DWI also offers the advantage of detecting the typical imaging features of stroke and confirming the presence or absence of this key alternative differential diagnosis.
Isolated cortical hyperintensity and combined cortical and deep gray matter (basal ganglia) hyperintensity are the two patterns of DWI and/or FLAIR abnormality that have been described (21) . One study has shown that 95% of patients demonstrate signal abnormality in at least three out of four discrete areas, to include the insula, cingulate gyrus, superior frontal gyrus, and occipital gyrus (22) . Though not a specific finding, one should recognize these isolated cortical hyperintensities as a pattern of suspicion for CJD in the setting of cognitive decline or other characteristic clinical findings (21) . Resolution of findings, pathologic enhancement, and cerebral edema are not commonly described imaging characteristics of CJD and can be useful findings when considering the differential diagnosis for CJD.
It is thought that involvement of the basal ganglia is a relatively late development in the course of the disease, and up to 33% of patients with CJD can present without basal ganglia hyperintensity (21, 23) . There is potential clinical significance associated with involvement of the deep gray matter, as a short disease course with rapidly progressing neurologic deterioration has been linked with the presence of basal ganglia imaging abnormality. In contrast, absence of basal ganglia involvement correlates with delayed onset of dementia and an extended disease course (24, 25) .
DWI is more sensitive than FLAIR in the detection of cortical abnormalities, especially in early stages of CJD. Several studies have shown that areas of the brain cortex with abnormal MRI signal have more severe histologic findings than areas with normal cortical signal 26, 27) . Furthermore, the distribution of brain hyperintensity can be shown to correspond with the clinical symptoms. It has been proposed that vacuole formation is the principal neuropathologic finding during early phases of CJD when spongiform changes predominate (28) . DWI, succinctly, is a MRI method that produces images based on the relative ability of water molecules to diffuse locally in the brain parenchyma, with areas of restricted water being displayed as increased brightness (hyperintensity). Vacuoles restrict water diffusion, resulting in DWI hyperintensity. This lends support to the apparent increased sensitivity of DWI early in the course of CJD. Clinically, abnormal diffusion characteristics have been observed prior to the onset of myoclonus or the finding of periodic sharp wave complexes on EEG (23) . In more advanced disease, however, DWI findings may become less conspicuous while the occurrence of FLAIR signal abnormalities is relatively more frequent (23) . The prevalence of FLAIR signal elevation is thought to coincide with the stages of CJD during which gliosis is the more widespread neuropathologic finding (28) .
In conclusion, CJD is more often a diagnosis of exclusion, requiring also a constellation of clinicopathologic attributes and supportive diagnostic exam findings. Undoubtedly, MRI utilizing FLAIR and DWI should be an essential component in the evaluation of patients with progressive cognitive decline. The ability to exclude possibly treatable etiologies and the potential for gaining prognostic information are some of the benefits of including MRI in the diagnostic workup in this patient population.
